The market has greeted relatively upbeat sales numbers from Clicks with a dose of scepticism. The health-care product retailer said on Tuesday group retail sales in the 20 weeks to January 13 were up 7.8%, or 4.5% excluding net new stores, thanks in part to selling-price increases of 1.1%. While sales growth has slowed — a year before, group retail sales rose 13% — other retailers have felt the pinch of SA’s economic malaise more acutely. Following the trading update, shares in Clicks immediately leapt to R202.50, the best level in nearly five months, though the stock retreated to a close of R194.99, a 0.8% decline on the day. Shares in rival group Dis-Chem Pharmacies fell 4% to R25, with most of the declines coming after Clicks’s update. With other retailers reporting weaker sales numbers, “I think the market is starting to question at what margin is Clicks able to achieve these stellar results”, said Gryphon Asset Management portfolio manager Casparus Treurnicht. More importantly,...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.